Published 2014 | Version v1
Book

Harmonization of radiobiological assays: why and how?

  • 1. Radiation Research Program, National Cancer Institute, Bethesda, MD 20892 (United States)

Description

The International Atomic Energy Agency has made available a technical manual for cytogenetic biodosimetry assays (dicentric chromosome aberration (DCA) and cytokinesis-block micronucleus (CBMN) assays) used for radiation dose assessment in radiation accidents. The International Standardization Organization, which develops standards and guidelines, also provides an avenue for laboratory accreditation, has developed guidelines and recommendations for performing cytogenetic biodosimetry assays. Harmonization of DCA and CBMN assays, has improved their accuracy. Double-blinded inter-laboratory comparison studies involving several networks have further validated DCA and CBMN assays and improved the confidence in their potential use for radiation dose assessment in mass casualties. This kind of international harmonization is lacking for pre-clinical radiobiology assays. The widely used pre-clinical assays that are relatively important to set stage for clinical trials include clonogenic assays, flow-cytometry assays, apoptotic assays, and tumor regression and growth delay assays. However, significant inter-laboratory variations occur with respect to data among laboratories. This raises concerns on the reliability and reproducibility of preclinical data that drives further development and translation. Lack of reproducibility may stem from a variety of factors such as poor scientist training, less than optimal experimental design, inadequate description of methodology, and impulse to publish only the positive data etc. Availability of technical manuals, standard operating procedures, accreditation avenues for laboratories performing such assays, inter-laboratory comparisons, and use of standardized protocols are necessary to enhance reliability and reproducibility. Thus, it is important that radiobiological assays are harmonized for laboratory protocols to ensure successful translation of pre-clinical research on radiation effect modulators to help design clinic trials with confidence. (author)

Part of:
Proceedings of the international conference on radiation biology: frontiers in radiobiology - immunomodulation, countermeasures and therapeutics: abstract book, souvenir and scientific programme

Additional details

Publishing Information

Publisher
Institute of Nuclear Medicine and Allied Sciences
Imprint Place
Delhi (India)
Imprint Title
Proceedings of the international conference on radiation biology: frontiers in radiobiology - immunomodulation, countermeasures and therapeutics: abstract book, souvenir and scientific programme
Imprint Pagination
314 p.
Journal Page Range
p. 43

Conference

Title
international conference on radiation biology: frontiers in radiobiology - immunomodulation, countermeasures and therapeutics
Acronym
ICRB-2014
Dates
11-13 Nov 2014
Place
New Delhi (India)

Optional Information